Cannabis Use Disorder Clinical Trial
Official title:
Reaching and Motivating Change in Teen Marijuana Smokers
Verified date | October 2016 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
This study will test a behavioral intervention tailored for adolescents who smoke marijuana
and have concerns about their use. The study's purpose is to determine whether this
intervention (two-sessions of motivational enhancement intervention followed by 12 months of
optional skills training) will be more effective in reducing the use of this drug if
augmented by three periodic motivational enhancement treatment check-in sessions as compared
to three periodic computer-based check-in sessions.
HYPOTHESES: (1) Participants in the motivational enhancement treatment check-ins (MCI)
condition will reduce their use of marijuana more than participants in the computer based
(Comp) condition and report fewer negative consequences. These differences are expected to
be greater at later follow-ups (i.e, 9, 12, and 15 months) after repeated check-ins exert a
cumulative effect. (2)Engagement in CBT sessions will be greater for those in the MCI
condition and will partially mediate the effect on marijuana related outcome indices. (3)
The MCI intervention will lead to increased self-efficacy, and decreased normative
perceptions of marijuana use by other teens that will also partially mediate the effect of
the intervention.
Status | Completed |
Enrollment | 252 |
Est. completion date | September 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 14 Years to 19 Years |
Eligibility |
Inclusion Criteria: 1. age (14-19 years old), 2. grade level (9th through 11th) and 3. marijuana use. Exclusion Criteria: Individuals will be excluded if: 1. they are not fluent in English, 2. they have a thought disorder that precludes full participation, 3. they refuse to accept randomization to condition, 4. they are high school seniors. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Denise Walker | National Institute on Drug Abuse (NIDA), Virginia Polytechnic Institute and State University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | frequency (number of days) of marijuana use | Global Appraisal of Individual Needs - I (self-report measure) | 60 days | No |
Primary | treatment utilization | Global Appraisal of Individual Needs - I | 90 days | No |
Primary | marijuana abuse/dependence symptoms | Global Appraisal of Individual Needs - I | 60 days | No |
Primary | engagement in cognitive behavioral skills training sessions | Frequency of attendance at optional in-school counseling sessions | 90 days | No |
Secondary | self-efficacy | Self-efficacy scale that assesses self-efficacy for avoiding marijuana use | 90 days | No |
Secondary | normative perceptions of peer marijuana use | Descriptive perceived norms concerning the frequency of marijuana use by other adolescents of the participant's age | 90 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05726617 -
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
|
N/A | |
Not yet recruiting |
NCT04139668 -
Vivitrol Treatment for Cannabis Use Disorder
|
Phase 2 | |
Completed |
NCT01656707 -
Adaptive Treatment for Adolescent Cannabis Use Disorders
|
N/A | |
Completed |
NCT03204305 -
Brain Imaging of Cannabinoid Receptors
|
Early Phase 1 | |
Completed |
NCT05005013 -
A Teleheath tDCS Approach to Decrease Cannabis Use
|
N/A | |
Recruiting |
NCT05292547 -
Repetitive Transcranial Magnetic Stimulation to People With Cannabis Use Disorder (SToP-C-rTMS x CUD)
|
N/A | |
Completed |
NCT02932215 -
Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder
|
Phase 1 | |
Completed |
NCT03430050 -
Progesterone for Cannabis Withdrawal
|
Early Phase 1 | |
Withdrawn |
NCT03629106 -
Effects of Cannabis Abstinence on Symptomology and Cognition in Bipolar Disorder
|
N/A | |
Completed |
NCT03334721 -
Gabapentin for Bipolar & Cannabis Use Disorders
|
Phase 2 | |
Recruiting |
NCT04721353 -
Reducing Cannabis Overuse With Prazosin
|
Phase 4 | |
Completed |
NCT03718520 -
The Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural Connectivity
|
||
Completed |
NCT03624933 -
Effects of Cannabis Abstinence on Symptoms and Cognition in Depression
|
N/A | |
Recruiting |
NCT05836207 -
Rewards for Cannabis Abstinence-study
|
N/A | |
Not yet recruiting |
NCT06114212 -
Deep Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
|
N/A | |
Recruiting |
NCT05855668 -
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
|
N/A | |
Recruiting |
NCT04517474 -
Comparing the Spanish Version of CANreduce With or Without Psychological Support and Treatment as Usual, Reducing Cannabis Use.
|
N/A | |
Recruiting |
NCT05885542 -
SCORE Emerging Adult Cannabis Use & Stress
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06085222 -
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
|
Phase 1 | |
Completed |
NCT03056482 -
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
|
Phase 4 |